LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    AstraZeneca shares: is the company a bargain after the vaccine candidate news?

    Jay Yao discusses whether he thinks AstraZeneca is a bargain given the recent release of the company’s Covid-19 vaccine candidate…

    Read more »

    Investing Articles

    At 8,000p, is FTSE 100 company AstraZeneca a share worth me buying right now?

    If the R&D pipeline can keep powering yearly increases in earnings near 26%, as forecast for next year, I reckon…

    Read more »

    Investing Articles

    AstraZeneca share price: Here’s my verdict after the Covid-19 vaccine news

    Jabran Khan provides his verdict on the AstraZeneca share price amid the recent Covid-19 vaccine breakthrough and recent performance.

    Read more »

    Investing Articles

    Covid-19 vaccine: 1 biotech stock that profits from AstraZeneca’s success

    Another Covid-19 vaccine may soon be available from AstraZeneca. Zaven Boyrazian analyses the results and finds a larger opportunity for…

    Read more »

    Investing Articles

    AstraZeneca share price: 4 reasons I’d buy after its Covid-19 vaccine results

    The AstraZeneca share price is down after it announced its Covid-19 vaccine results, but it’s unlikely to be affected much…

    Read more »

    Investing Articles

    Should I buy AstraZeneca shares on vaccine news?

    AstraZeneca shares are up by 80% in five years. Roland Head's been taking a look at the pharma stock as…

    Read more »

    Live: Coronavirus Market Crash Coverage

    Stock market rally: 2 dirt-cheap UK shares I’d buy today and hold forever

    I reckon these exciting UK shares could help me get extremely rich with my Stocks and Shares ISA. I think…

    Read more »

    Investing Articles

    The AstraZeneca share price nears its all-time high! Here’s what I’d do now

    Zaven Boyrazian breaks down the latest results from AstraZeneca to decide whether the share price is justified or pure speculation.

    Read more »

    Investing Articles

    2 stocks I wouldn’t want to own in a stock market crash

    It's good to be prepared for a stock market crash. Here are two shares this Fool is avoiding in her…

    Read more »

    Investing Articles

    Why I’m thinking of AstraZeneca as a great long-term buy

    Motley Fool contributor Jay Yao writes why he's looking at FTSE 100 component AstraZeneca as a great long-term investment.

    Read more »

    Investing Articles

    3 FTSE 100 stocks I’d buy to play India’s rise

    Motley Fool contributor Jay Yao writes why he thinks these three FTSE 100 stocks have substantial upside given the development…

    Read more »

    Investing Articles

    Why I’d buy these 2 UK dividend shares in an ISA today to make a passive income

    These two UK dividend shares could offer a growing passive income, in my view. Buying them in an ISA today…

    Read more »